Publication | Open Access
Neuroprotective Potential of a Small Molecule RET Agonist in Cultured Dopamine Neurons and Hemiparkinsonian Rats
23
Citations
86
References
2021
Year
BT44 holds potential for further development into a novel, possibly disease-modifying, therapy for PD.
| Year | Citations | |
|---|---|---|
Page 1
Page 1